Showing results (71-80 of 109) with videos related to
Sort By:
Pageof 11
Nature|May 8, 2020
Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-IKeisuke Yamamoto, Anthony Venida, Julian Yano, et al.Cancer Discovery|April 29, 2020
Selective Alanine Transporter Utilization Creates a Targetable Metabolic Niche in Pancreatic CancerSeth J Parker, Caroline R Amendola, Kate E R Hollinshead, et al.BMJ Open|October 2, 2017
Quantifying sociodemographic and income disparities in medical therapy and lifestyle among symptomatic patients with suspected coronary artery disease: a cross-sectional study in North AmericaJoseph A Ladapo, Adrian Coles, Rowena J Dolor, et al.Cancer Discovery|June 30, 2022
NCOA4-Mediated Ferritinophagy Is a Pancreatic Cancer Dependency via Maintenance of Iron Bioavailability for Iron-Sulfur Cluster ProteinsNaiara Santana-Codina, Maria Quiles Del Rey, Kevin S Kapner, et al.Cancer Discovery|April 22, 2021
Selective Modulation of a Pan-Essential Protein as a Therapeutic Strategy in CancerClare F Malone, Neekesh V Dharia, Guillaume Kugener, et al.Cancer Discovery|September 17, 2021
An <i>In Vivo</i> CRISPR Screening Platform for Prioritizing Therapeutic Targets in AMLShan Lin, Clément Larrue, Nastassja K Scheidegger, et al.Journal of Geriatric Oncology|August 12, 2024
Association between frailty and overall survival among older adults with hepatocellular carcinomaAhmet Anil Ozluk, Grant Richard Williams, Chen Dai, et al.Biorxiv : the Preprint Server for Biology|April 15, 2024
Recharacterization of RSL3 reveals that the selenoproteome is a druggable target in colorectal cancerStephen L DeAngelo, Liang Zhao, Sofia Dziechciarz, et al.Cancer Research|May 20, 2025
Recharacterization of the Tumor Suppressive Mechanism of RSL3 Identifies the Selenoproteome as a Druggable Pathway in Colorectal CancerStephen L DeAngelo, Liang Zhao, Sofia Dziechciarz, et al.Frontiers in Immunology|June 17, 2021
The Immunology of Hormone Receptor Positive Breast CancerJonathan Goldberg, Ricardo G Pastorello, Tuulia Vallius, et al.Pageof 11